These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36804121)

  • 21. Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis.
    Nemeth JA; Yousif R; Herzog M; Che M; Upadhyay J; Shekarriz B; Bhagat S; Mullins C; Fridman R; Cher ML
    J Natl Cancer Inst; 2002 Jan; 94(1):17-25. PubMed ID: 11773278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Karyopherin beta 1 suppresses prostate cancer growth.
    Yang J; Guo Y; Lu C; Zhang R; Wang Y; Luo L; Zhang Y; Chu CH; Wang KJ; Obbad S; Yan W; Li X
    Oncogene; 2019 Jun; 38(24):4700-4714. PubMed ID: 30742095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
    Zhang YX; Kong CZ
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fli-1 Activation through Targeted Promoter Activity Regulation Using a Novel 3', 5'-diprenylated Chalcone Inhibits Growth and Metastasis of Prostate Cancer Cells.
    Ma Y; Xu B; Yu J; Huang L; Zeng X; Shen X; Ren C; Ben-David Y; Luo H
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells.
    Nadiminty N; Tummala R; Lou W; Zhu Y; Zhang J; Chen X; eVere White RW; Kung HJ; Evans CP; Gao AC
    J Biol Chem; 2012 Jan; 287(2):1527-37. PubMed ID: 22128178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MHY-449, a novel dihydrobenzofuro[4,5-b][1,8] naphthyridin-6-one derivative, induces apoptotic cell death through modulation of Akt/FoxO1 and ERK signaling in PC3 human prostate cancer cells.
    Lee SH; Kang YJ; Sung B; Kim DH; Lim HS; Kim HR; Kim SJ; Yoon JH; Moon HR; Chung HY; Kim ND
    Int J Oncol; 2014 Mar; 44(3):905-11. PubMed ID: 24424889
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
    Maxwell PJ; Neisen J; Messenger J; Waugh DJ
    Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression.
    Huang W; He T; Chai C; Yang Y; Zheng Y; Zhou P; Qiao X; Zhang B; Liu Z; Wang J; Shi C; Lei L; Gao K; Li H; Zhong S; Yao L; Huang ME; Lei M
    PLoS One; 2012; 7(5):e37693. PubMed ID: 22666381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L; Zhu Z; Joshi B; Porter AT; Tang DG
    Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
    Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
    Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of tumor growth and sensitization to chemotherapy by RNA interference targeting interleukin-6 in the androgen-independent human prostate cancer PC3 model.
    Sakai I; Miyake H; Terakawa T; Fujisawa M
    Cancer Sci; 2011 Apr; 102(4):769-75. PubMed ID: 21214673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reduction of IL-6 gene expression, pAKT, pERK1/2, pSTAT3 signaling pathways and invasion activity by gallic acid in prostate cancer PC3 cells.
    Heidarian E; Keloushadi M; Ghatreh-Samani K; Valipour P
    Biomed Pharmacother; 2016 Dec; 84():264-269. PubMed ID: 27665471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA let-7c Inhibits Cell Proliferation and Induces Cell Cycle Arrest by Targeting CDC25A in Human Hepatocellular Carcinoma.
    Zhu X; Wu L; Yao J; Jiang H; Wang Q; Yang Z; Wu F
    PLoS One; 2015; 10(4):e0124266. PubMed ID: 25909324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of ubiquitin specific protease 17 restrains prostate cancer proliferation by regulation of epithelial-to-mesenchymal transition (EMT) via ROS production.
    Baohai X; Shi F; Yongqi F
    Biomed Pharmacother; 2019 Oct; 118():108946. PubMed ID: 31377470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin E2 receptor EP4 is involved in the cell growth and invasion of prostate cancer via the cAMP‑PKA/PI3K‑Akt signaling pathway.
    Xu S; Zhou W; Ge J; Zhang Z
    Mol Med Rep; 2018 Mar; 17(3):4702-4712. PubMed ID: 29328471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of N-myc downstream-regulated gene 2 in prostatic carcinoma.
    Yu C; Wu G; Dang N; Zhang W; Zhang R; Yan W; Zhao Y; Gao L; Wang Y; Beckwith N; Yuan J; Yao L
    Cancer Biol Ther; 2011 Aug; 12(4):304-13. PubMed ID: 21623166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual STAT‑3 and IL‑6R inhibition with stattic and tocilizumab decreases migration, invasion and proliferation of prostate cancer cells by targeting the IL‑6/IL‑6R/STAT‑3 axis.
    Méndez-Clemente A; Bravo-Cuellar A; González-Ochoa S; Santiago-Mercado M; Palafox-Mariscal L; Jave-Suárez L; Solorzano-Ibarra F; Villaseñor-García M; Ortiz-Lazareno P; Hernández-Flores G
    Oncol Rep; 2022 Aug; 48(2):. PubMed ID: 35703345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipose-derived stromal cells inhibit prostate cancer cell proliferation inducing apoptosis.
    Takahara K; Ii M; Inamoto T; Komura K; Ibuki N; Minami K; Uehara H; Hirano H; Nomi H; Kiyama S; Asahi M; Azuma H
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1102-7. PubMed ID: 24680678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the expression and association of retinoblastoma binding protein 6 with the JNK signaling pathway in prostate cancers.
    Guan WY; Zhao S; Luo YN
    Cell Biol Int; 2020 Oct; 44(10):2107-2119. PubMed ID: 32662898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Tanshinone Analog Exerts Anti-Cancer Effects in Prostate Cancer by Inducing Cell Apoptosis, Arresting Cell Cycle at G2 Phase and Blocking Metastatic Ability.
    Wang M; Zeng X; Li S; Sun Z; Yu J; Chen C; Shen X; Pan W; Luo H
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.